|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA-Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ramalingam SS, Owonikoko TK and Khuri FR:
Lung cancer: New biological insights and recent therapeutic
advances. CA Cancer J Clin. 61:91–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Goldstraw P, Crowley J, Chansky K, Giroux
DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V and Sobin L;
International Association for the Study of Lung Cancer
International Staging Committee, ; Participating Institutions, :
The IASLC lung cancer staging project: Proposals for the revision
of the TNM stage groupings in the forthcoming (seventh) edition of
the TNM Classification of malignant tumours. J Thorac Oncol.
2:706–714. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pantel K, Brakenhoff RH and Brandt B:
Detection, clinical relevance and specific biological properties of
disseminating tumour cells. Nat Rev Cancer. 8:329–340. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamashita JI, Kurusu Y, Fujino N, Saisyoji
T and Ogawa M: Detection of circulating tumor cells in patients
with non-small cell lung cancer undergoing lobectomy by
video-assisted thoracic surgery: A potential hazard for
intraoperative hematogenous tumor cell dissemination. J Thorac
Cardiovasc Surg. 119:899–905. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dong Q, Huang J, Zhou Y, Li L, Bao G, Feng
J and Sha H: Hematogenous dissemination of lung cancer cells during
surgery: Quantitative detection by flow cytometry and prognostic
significance. Lung Cancer. 37:293–301. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Allard WJ, Matera J, Miller MC, Repollet
M, Connelly MC, Rao C, Tibbe AG, Uhr JW and Terstappen LW: Tumor
cells circulate in the peripheral blood of all major carcinomas but
not in healthy subjects or patients with nonmalignant diseases.
Clin Cancer Res. 10:6897–6904. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LW and Hayes DF: Circulating tumor cells, disease
progression, and survival in metastatic breast cancer. N Engl J
Med. 351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tanaka F, Yoneda K, Kondo N, Hashimoto M,
Takuwa T, Matsumoto S, Okumura Y, Rahman S, Tsubota N, Tsujimura T,
et al: Circulating tumor cell as a diagnostic marker in primary
lung cancer. Clin Cancer Res. 15:6980–6986. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Krebs MG, Sloane R, Priest L, Lancashire
L, Hou JM, Greystoke A, Ward TH, Ferraldeschi R, Hughes A, Clack G,
et al: Evaluation and prognostic significance of circulating tumor
cells in patients with non-small-cell lung cancer. J Clin Oncol.
29:1556–1563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Okumura Y, Tanaka F, Yoneda K, Hashimoto
M, Takuwa T, Kondo N and Hasegawa S: Circulating tumor cells in
pulmonary venous blood of primary lung cancer patients. Ann Thorac
Surg. 87:1669–1675. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hashimoto M, Tanaka F, Yoneda K, Takuwa T,
Matsumoto S, Okumura Y, Kondo N, Tsubota N, Tsujimura T, Tabata C,
et al: Significant increase in circulating tumour cells in
pulmonary venous blood during surgical manipulation in patients
with primary lung cancer. Interact Cardiovasc Thorac Surg.
18:775–783. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rami-Porta R, Wittekind C and Goldstraw P;
International Association for the Study of Lung Cancer (IASLC)
Staging Committee, : Complete resection in lung cancer surgery:
Proposed definition. Lung Cancer. 49:25–33. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mountain CF and Dresler CM: Regional lymph
node classification for lung cancer staging. Chest. 111:1718–1723.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hou JM, Krebs MG, Lancashire L, Sloane R,
Backen A, Swain RK, Priest LJ, Greystoke A, Zhou C, Morris K, et
al: Clinical significance and molecular characteristics of
circulating tumor cells and circulating tumor microemboli in
patients with small-cell lung cancer. J Clin Oncol. 30:525–532.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kurusu Y, Yamashita J, Hayashi N, Mita S,
Fujino N and Ogawa M: The sequence of vessel ligation affects tumor
release into the circulation. J Thorac Cardiovasc Surg.
116:107–113. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Refaely Y, Sadetzki S, Chetrit A, Simansky
DA, Paley M, Modan B and Yellin A: The sequence of vessel
interruption during lobectomy for non-small cell lung cancer: Is it
indeed important? J Thorac Cardiovasc Surg. 125:1313–1320. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fieira Costa E, Delgado Roel M, Paradela
de la Morena M, Gonzalez-Rivas D, Fernandez-Prado R and de la Torre
M: Technique of uniportal VATS major pulmonary resections. J Thorac
Dis. 6 Suppl 6:S660–S664. 2014.PubMed/NCBI
|
|
20
|
Glaves D: Correlarion between circulating
cancer cells and incidence of metastases. Br J Cancer. 48:665–673.
1983. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sienel W, Seen-Hibler R, Mutschler W,
Pantel K and Passlick B: Tumour cells in the tumour draining vein
of patients with non-small cell lung cancer: Detection rate and
clinical significance. Eur J Cardiothorac Surg. 23:451–456. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Funaki S, Sawabata N, Nakagiri T, Shintani
Y, Inoue M, Kadota Y, Minami M and Okumura M: Novel approach for
detection of isolated tumor cells in pulmonary vein using negative
selection method: Morphological classification and clinical
implications. Eur J Cardiothorac Surg. 40:322–327. 2011.PubMed/NCBI
|
|
23
|
Pataer A, Kalhor N, Correa AM, Raso MG,
Erasmus JJ, Kim ES, Behrens C, Lee JJ, Roth JA, Stewart DJ, et al:
Histopathologic response criteria predict survival of patients with
resected lung cancer after neoadjuvant chemotherapy. J Thorac
Oncol. 7:825–832. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
William WN Jr, Pataer A, Kalhor N, Correa
AM, Rice DC, Wistuba II, Heymach J, Lee JJ, Kim ES, Munden R, et
al: Computed tomography RECIST assessment of histopathologic
response and prediction of survival in patients with resectable
non-small-cell lung cancer after neoadjuvant chemotherapy. J Thorac
Oncol. 8:222–228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Baccelli I, Schneeweiss A, Riethdorf S,
Stenzinger A, Schillert A, Vogel V, Klein C, Saini M, Bäuerle T,
Wallwiener M, et al: Identification of a population of blood
circulating tumor cells from breast cancer patients that initiates
metastasis in a xenograft assay. Nat Biotechnol. 31:539–544. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun YF, Xu Y, Yang XR, Guo W, Zhang X, Qiu
SJ, Shi RY, Hu B, Zhou J and Fan J: Circulating stem cell-like
epithelial cell adhesion molecule-positive tumor cells indicate
poor prognosis of hepatocellular carcinoma after curative
resection. Hepatology. 57:1458–1468. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hodgkinson CL, Morrow CJ, Li Y, Metcalf
RL, Rothwell DG, Trapani F, Polanski R, Burt DJ, Simpson KL, Morris
K, et al: Tumorigenicity and genetic profiling of circulating tumor
cells in small-cell lung cancer. Nat Med. 20:897–903. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Z, Shiratsuchi H, Lin J, Chen G,
Reddy RM, Azizi E, Fouladdel S, Chang AC, Lin L, Jiang H, et al:
Expansion of CTCs from early stage lung cancer patients using a
microfluidic co-culture model. Oncotarget. 5:12383–12397. 2014.
View Article : Google Scholar : PubMed/NCBI
|
